Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
La Revue De Medecine Interne|May 2, 2019
[Acute carpal tunnel syndrome caused by a thrombosis of a persistent median artery: 2 case reports]M Avenel, S Miranda, Y Benhamou, et al.Diagnostic and Interventional Imaging|September 15, 2019
Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mappingE Deborde, B Dubourg, S Bejar, et al.Diagnostic and Interventional Imaging|January 9, 2018
Multidetector computed tomography sizing of aortic annulus prior to transcatheter aortic valve replacement (TAVR): Variability and impact of observer experienceS Le Couteulx, J Caudron, B Dubourg, et al.Indian Journal of Nephrology|January 27, 2023
Effect of Dialyzer Reuse on the Activity of Paraoxonase 1 in Patients on HemodialysisReynaldo Miguita, Andressa K Matsumoto, Ana P Michelin, et al.Gynecologic Oncology|October 24, 2007
Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)David S Alberts, P Y Liu, Sharon P Wilczynski, et al.Gynecologic Oncology|January 2, 2010
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trialMaurie Markman, James Moon, Sharon Wilczynski, et al.Gynecologic Oncology|March 19, 2011
A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignanciesLydia Usha, Michael W Sill, Kathleen M Darcy, et al.CNS Spectrums|July 9, 2020
Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocationAndressa K Matsumoto, Michael Maes, Thitiporn Supasitthumrong, et al.Revista Clinica Espanola|July 4, 2019
Is oxidative stress associated with disease severity, pulmonary function and metabolic syndrome in chronic obstructive pulmonary disease?W A Sepúlveda Loyola, F Vilaça Cavallari Machado, L Araújo de Castro, et al.JCO Precision Oncology|April 11, 2024
Regorafenib in Patients With Solid Tumors With <i>BRAF</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyVaibhav Sahai, Michael Rothe, Pam K Mangat, et al.Pageof 2